Cancer Research Technology Limited (CRT) is the cancer-focused technology development and commercialisation arm of Cancer Research UK, the world’s largest cancer charity. We have built our reputation over the last 20 years thanks to our exclusive understanding of the cancer market and the needs of those who work within it, whether their interest is academic, commercial or clinical, and we have an enviable track record to prove it.
We are unique in the technology transfer world in that we focus solely on cancer. In addition, we offer a breadth of services and expertise – from discovery to early clinical development capability - and through our subsidiary CRT Inc, and network of partners, have the ability to source projects globally, facilitating complementary partnerships between academics and industry.
At CRT, it is our mission to maximise the potential benefit to cancer patients flowing from publicly funded cancer research. We achieve this through translating discoveries into cancer therapeutics, vaccines or diagnostics in partnership with industry.
© Cancer Research Technology 2012